Table 2.
Variables | Univariate analysis | Multivariate analysis | |
---|---|---|---|
P‐value | HR (95% CI) | P‐value | |
Age (years) | <.001 | .288 | |
˂40 | Reference | ||
40‐49 | 1.111 (0.795, 1.554) | .537 | |
50‐59 | 1.082 (0.793, 1.476) | .620 | |
60‐75 | 1.088 (0.796, 1.489) | .596 | |
>75 | 1.423 (0.991, 2.042) | .056 | |
Race | <.001 | <.001 | |
White | Reference | ||
Black | 1.586 (1.285, 1.957) | <.001 | |
Othera | 0.962 (0.655, 1.413) | .843 | |
Marital status | <.001 | .011 | |
Married | Reference | ||
Unmarried | 1.235 (1.049, 1.454) | ||
Grade | .021 | .258 | |
Grade I/II | Reference | ||
Grade III/IV | 1.091 (0.881, 1.350) | ||
Unknown | 0.914 (0.709, 1.179) | ||
N stage | .047 | .002 | |
N0 | Reference | ||
N1 | 0.993 (0.779, 1.265) | .954 | |
N2 | 1.213 (0.909, 1.618) | .190 | |
N3 | 1.460 (1.122, 1.901) | .005 | |
M stage | <.001 | <.001 | |
M0 | Reference | ||
M1 | 2.248 (1.850, 2.733) | ||
Tumor extensionb | .087 | .140 | |
<50% | Reference | ||
≥50% | 1.215 (0.999, 1.479) | .052 | |
Unknown | 1.016 (0.731, 1.412) | .923 | |
HoR | <.001 | <.001 | |
Negative | Reference | ||
Positive | 0.521 (0.437, 0.621) | <.001 | |
Unknown | 1.048 (0.764, 1.438) | .771 | |
HER, 2 | .001 | .001 | |
Negative | Reference | ||
Positive | 0.425 (0.274, 0.661) | <.001 | |
Unknown | 0.810 (0.636, 1.030) | .085 | |
Surgery | <.001 | <.001 | |
No surgery | Reference | ||
Partial mastectomy | 0.613 (0.407, 0.922) | .019 | |
Simple mastectomy | 0.532 (0.386, 0.733) | <.001 | |
Radical mastectomy | 0.592 (0.472, 0.743) | <.001 | |
Chemotherapy | <.001 | <.001 | |
No/unknown | Reference | ||
Yes | 0.464 (0.370, 0.583) | ||
Radiotherapy | <.001 | .010 | |
No/unknown | Reference | ||
Yes | 0.794 (0.666, 0.946) |
Abbreviation: HoR, hormone receptor.
Other includes American Indian/Alaska native, Asian/Pacific Islander.
Tumor extension means the percentage of the area of tumors in the unilateral breast.